根据ESI于2021年7月8日发布的数据，我校高被引论文（Highly Cited Papers）188篇，热点论文（Hot Papers）14篇，见附件：2021年7月yl23455永利高被引论文及热点论文简表。详情如下。
从学科角度看，在188篇高被引论文中，临床医学最多（97篇），占比51.60%，分子生物学与遗传学（20篇）第二，占比10.64%，生物学与生物化学、药理学与毒理学均为12篇（6.38%）紧跟其后。
|
序号 |
高被引论文 Research Field |
202105 |
202107 |
||
|
论文数 |
占比 |
论文数 |
占比 |
||
|
1 |
CLINICAL MEDICINE |
92 |
53.49% |
97 |
51.60% |
|
2 |
MOLECULAR BIOLOGY & GENETICS |
18 |
10.47% |
20 |
10.64% |
|
3 |
BIOLOGY & BIOCHEMISTRY |
12 |
6.98% |
12 |
6.38% |
|
4 |
PHARMACOLOGY & TOXICOLOGY |
10 |
5.81% |
12 |
6.38% |
|
5 |
NEUROSCIENCE & BEHAVIOR |
7 |
4.07% |
8 |
4.26% |
|
6 |
ENGINEERING |
2 |
1.16% |
3 |
1.60% |
|
7 |
MICROBIOLOGY |
8 |
4.65% |
7 |
3.72% |
|
8 |
AGRICULTURAL SCIENCES |
2 |
1.16% |
2 |
1.06% |
|
9 |
CHEMISTRY |
3 |
1.74% |
5 |
2.66% |
|
10 |
PHYSICS |
2 |
1.16% |
2 |
1.06% |
|
11 |
MATERIALS SCIENCE |
4 |
2.33% |
7 |
3.72% |
|
12 |
PSYCHIATRY/PSYCHOLOGY |
4 |
2.33% |
4 |
2.13% |
|
13 |
MULTIDISCIPLINARY |
1 |
0.58% |
1 |
0.53% |
|
14 |
IMMUNOLOGY |
1 |
0.58% |
2 |
1.06% |
|
15 |
ENVIRONMENT/ECOLOGY |
2 |
1.16% |
1 |
0.53% |
|
16 |
SOCIAL SCIENCES, GENERAL |
2 |
1.16% |
2 |
1.06% |
|
17 |
COMPUTER SCIENCE |
1 |
0.58% |
2 |
1.06% |
|
18 |
GEOSCIENCES |
1 |
0.58% |
1 |
0.53% |
|
19 |
合计 |
172 |
100.00% |
188 |
100.00% |
|
序号 |
2021年7月我校14篇热点论文 标题 |
来源期刊 |
DOI |
Research Field |
Times Cited |
|
1 |
CLINICAL CHARACTERISTICS OF CORONAVIRUS DISEASE 2019 IN CHINA |
NEW ENGLAND JOURNAL OF MEDICINE 382 (18): 1708-1720 APR 30 2020 |
10.1056/NEJMoa2002032 |
CLINICAL MEDICINE |
7471 |
|
2 |
CORONAVIRUS INFECTIONS AND IMMUNE RESPONSES |
JOURNAL OF MEDICAL VIROLOGY 92 (4): 424-432 SP. ISS. SI APR 2020 |
10.1002/jmv.25685 |
MICROBIOLOGY |
530 |
|
3 |
COMORBIDITY AND ITS IMPACT ON 1590 PATIENTS WITH COVID-19 IN CHINA: A NATIONWIDE ANALYSIS |
EUROPEAN RESPIRATORY JOURNAL 55 (5): - MAY 1 2020 |
10.1183/13993003.00547-2020 |
CLINICAL MEDICINE |
440 |
|
4 |
DEVELOPMENT AND VALIDATION OF A CLINICAL RISK SCORE TO PREDICT THE OCCURRENCE OF CRITICAL ILLNESS IN HOSPITALIZED PATIENTS WITH COVID-19 |
JAMA INTERNAL MEDICINE 180 (8): 1081-1089 AUG 2020 |
10.1001/jamainternmed.2020.2033 |
CLINICAL MEDICINE |
221 |
|
5 |
PROGRESSION OF MENTAL HEALTH SERVICES DURING THE COVID-19 OUTBREAK IN CHINA |
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES 16 (10): 1732-1738 2020 |
10.7150/ijbs.45120 |
BIOLOGY & BIOCHEMISTRY |
220 |
|
6 |
DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE |
NEW ENGLAND JOURNAL OF MEDICINE 383 (15): 1436-1446 OCT 8 2020 |
10.1056/NEJMoa2024816 |
CLINICAL MEDICINE |
156 |
|
7 |
EFFECT OF LAPAROSCOPIC VS OPEN DISTAL GASTRECTOMY ON 3-YEAR DISEASE-FREE SURVIVAL IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER THE CLASS-01 RANDOMIZED CLINICAL TRIAL |
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 321 (20): 1983-1992 MAY 28 2019 |
10.1001/jama.2019.5359 |
CLINICAL MEDICINE |
125 |
|
8 |
SURVEY OF INSOMNIA AND RELATED SOCIAL PSYCHOLOGICAL FACTORS AMONG MEDICAL STAFF INVOLVED IN THE 2019 NOVEL CORONAVIRUS DISEASE OUTBREAK |
FRONTIERS IN PSYCHIATRY 11: - APR 14 2020 |
10.3389/fpsyt.2020.00306 |
PSYCHIATRY/PSYCHOLOGY |
117 |
|
9 |
ROXADUSTAT TREATMENT FOR ANEMIA IN PATIENTS UNDERGOING LONG-TERM DIALYSIS |
NEW ENGLAND JOURNAL OF MEDICINE 381 (11): 1011-1022 SEP 12 2019 |
10.1056/NEJMoa1901713 |
CLINICAL MEDICINE |
113 |
|
10 |
KIKUCHI DISEASE AS A POSSIBLE CAUSE OF ISCHAEMIC STROKE: A CASE REPORT |
INTERNATIONAL JOURNAL OF NEUROSCIENCE : - MAY 6 2020 |
10.1080/00207454.2020.1763341 |
NEUROSCIENCE & BEHAVIOR |
111 |
|
11 |
STRUCTURAL AND FUNCTIONAL PROPERTIES OF SARS-COV-2 SPIKE PROTEIN: POTENTIAL ANTIVIRUS DRUG DEVELOPMENT FOR COVID-19 |
ACTA PHARMACOLOGICA SINICA 41 (9): 1141-1149 SEP 2020 |
10.1038/s41401-020-0485-4 |
PHARMACOLOGY & TOXICOLOGY |
73 |
|
12 |
RAPID AND SENSITIVE DETECTION OF ANTI-SARS-COV-2 IGG, USING LANTHANIDE-DOPED NANOPARTICLES-BASED LATERAL FLOW IMMUNOASSAY |
ANALYTICAL CHEMISTRY 92 (10): 7226-7231 MAY 19 2020 |
10.1021/acs.analchem.0c00784 |
CHEMISTRY |
70 |
|
13 |
THE PREVALENCE AND INFLUENCING FACTORS IN ANXIETY IN MEDICAL WORKERS FIGHTING COVID-19 IN CHINA: A CROSS-SECTIONAL SURVEY |
EPIDEMIOLOGY AND INFECTION 148: - 2020 |
10.1017/S0950268820001107 |
SOCIAL SCIENCES, GENERAL |
48 |
|
14 |
NATURAL PRODUCTS AS LSD1 INHIBITORS FOR CANCER THERAPY |
ACTA PHARMACEUTICA SINICA B 11 (3): 621-631 MAR 2021 |
10.1016/j.apsb.2020.06.007 |
PHARMACOLOGY & TOXICOLOGY |
13 |